Lifetime cost-effectiveness analysis osseointegrated transfemoral versus socket prosthesis using Markov modelling.

Jeffrey D VoigtBenjamin K PotterJason SouzaJonathan ForsbergDanielle MeltonJoseph R HsuBenjamin Wilke

Published in: Bone & joint open (2024)

The use of the OPRA prosthesis in physically active transfemoral amputees should be considered as a cost-effective alternative in both treatment-naïve and treatment-refractory socket prosthesis patients. Disease-specific quality of life assessments such as Q-TFA are more sensitive when evaluating cost-effectiveness.

Keyphrases

transcatheter aortic valve replacement
transcatheter aortic valve implantation
end stage renal disease
ejection fraction
newly diagnosed
aortic valve replacement
prognostic factors
heart failure
coronary artery disease
aortic valve
patient reported outcomes
replacement therapy